Differential diagnosis for melena is the systematic process of identifying potential underlying causes of black, tarry stools resulting from upper gastrointestinal bleeding. This condition stems from digested blood in the GI tract, most often due to lesions in the esophagus, stomach, or duodenum. Accurate differentiation prevents mismanagement of life-threatening conditions.
Melena occurs when hemoglobin in blood is altered by gastric acid and digestive enzymes, turning stool dark brown to black. The color change typically indicates bleeding above the ligament of Treitz-the junction between the duodenum and jejunum. A single episode of melena may stem from minor causes like NSAID use, but persistent or recurrent episodes require urgent evaluation to rule out malignancy, peptic ulcer disease, or vascular anomalies.
According to the American Gastroenterological Association, upper GI bleeding accounts for approximately 100,000 hospitalizations annually in the U.S., with melena present in 60-70% of cases. The presence of melena alone does not confirm the site of hemorrhage-some lower GI bleeds can mimic melena if transit time is delayed. Thus, clinical context, lab values, and endoscopic findings are essential.
Diagnosis begins with history and physical exam. Key questions include recent NSAID or anticoagulant use, alcohol consumption, prior ulcers, or family history of GI cancers. Patients may report epigastric pain, fatigue, or dizziness-signs of anemia. Physical signs such as pallor, orthostatic hypotension, or a positive fecal occult blood test (FOBT) support ongoing bleeding.
Laboratory tests follow. Hemoglobin below 12 g/dL in women or 13 g/dL in men suggests significant blood loss. Elevated BUN-to-creatinine ratio (>30:1) indicates prerenal azotemia from volume depletion. A drop in hematocrit over time confirms active bleeding. These results guide urgency of intervention.
Endoscopy remains the gold standard. Upper GI endoscopy (esophagogastroduodenoscopy, or EGD) allows direct visualization of the esophagus, stomach, and duodenum. It detects ulcers, varices, tumors, and erosions. The procedure is performed within 24 hours of admission for high-risk patients, including those with hemodynamic instability or comorbidities like heart failure.
The following list includes the most common etiologies, ranked by frequency and clinical significance. Conditions are grouped by anatomical origin and pathophysiology.
| Rank | Condition | Prevalence (%) | Key Features |
|---|---|---|---|
| 1 | Peptic Ulcer Disease (PUD) | 40-50 | Epigastric pain, NSAID or H. pylori exposure, visible ulcer on EGD |
| 2 | Esophageal Varices | 15-20 | History of cirrhosis, portal hypertension, red wale sign on endoscopy |
| 3 | Gastric Cancer | 5-10 | Weight loss, anorexia, older age, biopsy-proven adenocarcinoma |
| 4 | Stress Ulcers | 8-12 | ICU admission, mechanical ventilation, corticosteroid use |
| 5 | Dieulafoy's Lesion | 1-2 | Small, abnormal artery in stomach wall; sudden massive bleed with minimal symptoms |
| 6 | Esophagitis (Reflux or Infectious) | 5-8 | Heartburn, dysphagia, endoscopic mucosal damage, often associated with GERD or Candida |
| 7 | Angiodysplasia | 3-5 | Older adults, intermittent bleeding, vascular malformations seen on EGD or capsule endoscopy |
| 8 | Portal Hypertensive Gastropathy | 3-5 | Chronic liver disease, diffuse mucosal changes resembling watermelon stomach |
| 9 | Medication-Induced Bleeding | 10-15 | Aspirin, clopidogrel, warfarin, NSAIDs; often reversible upon discontinuation |
| 10 | Small Bowel Bleeding (Rare Source) | <1 | Delayed transit, negative EGD, requires capsule endoscopy or enteroscopy |
Peptic ulcer disease is the leading cause of melena, responsible for nearly half of all upper GI bleeds. It arises from imbalance between aggressive factors (acid, pepsin, H. pylori) and defensive mechanisms (mucus, bicarbonate, blood flow). H. pylori infection is confirmed via urea breath test or stool antigen testing. Treatment involves proton pump inhibitors (PPIs), antibiotics (e.g., clarithromycin, amoxicillin), and cessation of NSAIDs.
Variceal bleeding, while less common, carries higher mortality. A study in *Gastroenterology* reported a 15-day mortality rate of 20% in patients with active variceal hemorrhage. Endoscopic band ligation is first-line therapy, combined with vasoconstrictors like octreotide to reduce portal pressure.
Many assume melena always means upper GI bleeding. But slow colonic transit can result in dark stool from lower GI sources-especially in elderly patients with constipation or iron supplementation. Iron supplements alone can produce melena-like stools without actual blood loss. A 2021 study in *The American Journal of Gastroenterology* found that 12% of patients with iron-induced melena were incorrectly diagnosed with GI bleeding initially.
Another error is assuming all melena requires immediate endoscopy. Low-risk patients with stable vitals, mild anemia, and no warning signs (e.g., syncope, hematemesis) may undergo non-invasive workup first. The Rockall score helps stratify risk. A score ≤3 indicates low risk; these patients can be evaluated outpatient with FOBT and hemoglobin monitoring.
Some clinicians confuse melena with hematochezia-bright red blood in stool. Hematochezia implies lower GI bleeding, usually from the colon or rectum. Distinguishing them is critical: hematochezia may indicate diverticulosis, inflammatory bowel disease, or colorectal cancer. A patient with melena and hematochezia together signals a complex bleed, possibly from a tumor or arteriovenous malformation.
A 68-year-old man presents with two days of black stools and fatigue. He takes aspirin daily for coronary artery disease and reports occasional heartburn. On exam, he is pale and has a blood pressure of 98/60 mmHg. Hemoglobin is 8.2 g/dL. BUN is 28 mg/dL, creatinine 1.1 mg/dL-ratio 25:1.
Initial workup shows positive FOBT. EGD reveals a 1.5 cm ulcer in the duodenal bulb with active oozing. Biopsy confirms H. pylori positivity. The patient receives IV PPI, iron replacement, and is started on clarithromycin-amoxicillin triple therapy. He stabilizes within 48 hours and is discharged on oral PPI and aspirin continuation under cardiology follow-up.
This case illustrates how differential diagnosis for melena guides targeted treatment. Without endoscopy, the cause might have been missed. The combination of history, labs, and visual confirmation led to accurate management.
When melena persists despite treatment, further imaging is needed. CT angiography can detect arterial bleeding sources not visible on EGD. Capsule endoscopy is used for suspected small bowel pathology. Colonoscopy is reserved for patients with mixed hematochezia and melena, or when EGD is normal.
For patients with chronic melena and no clear source, consider inherited bleeding disorders like von Willebrand disease or platelet function defects. A coagulation panel and bleeding time test help identify these rare causes.
One non-obvious fact: melena can appear within 6-12 hours of a significant upper GI bleed. Delayed onset beyond 24 hours suggests slower, intermittent bleeding-common in angiodysplasia or early malignancy. This timing insight aids in triaging patients based on symptom duration.
As a clinician, I've seen a patient with long-term NSAID use present with melena and confusion. Initial labs showed severe anemia. EGD revealed a large gastric ulcer. After stabilization and endoscopic clipping, the patient recovered-but only after the diagnosis was not delayed by assuming the cause was non-gastrointestinal.
Understanding differential diagnosis for melena ensures timely intervention. Early identification of life-threatening causes like varices or malignancy reduces mortality. Always correlate clinical findings with diagnostic tools rather than relying on stool appearance alone.